Research Use Only — Not for Human Consumption. This compound is sold exclusively for in vitro laboratory research by qualified professionals.
RETA-20
Retatrutide 20 mg
RETA-20 provides 20 mg of retatrutide for medium-scale research protocols. This quantity supports multi-week animal dosing studies or comprehensive in vitro receptor characterization across all three target receptor pathways. For research use only — not for human consumption.
Third-Party Tested. Every Lot.
Every batch of RETA-20 undergoes independent HPLC and mass spectrometry analysis through an accredited third-party laboratory before it is released for sale. No exceptions. No internal-only certificates.
RP-HPLC Analysis
Every lot measured by reverse-phase HPLC. RETA-20 consistently achieves 99.0%+ purity across batches.
ESI Mass Spec
Electrospray ionization mass spectrometry confirms exact molecular weight and rules out structural isomers or impurities.
Lot-Specific CoA
Your Certificate of Analysis references your exact lot number with actual chromatogram data — not a generic template.
Theoretical Research Analysis
All research information below reflects published preclinical literature only. This product is not for human use, consumption, or clinical application of any kind.
Suitable for 4–8 week animal protocols at standard research doses. The triple-agonist mechanism is best characterized through parallel receptor activation studies at each target site.
Sequence Information
Amino acid sequence:
Y-Aib-IGTFTSDYSIALDK(C₁₈ fatty acid)EQAAK(glucagon motif)DFIEWLQNGGMolecular Formula
C₂₁₅H₃₃₂N₅₆O₆₄
Molecular Weight
4641.20 g/mol
You May Also Like
View allTIRZ-60
Tirzepatide 60 mg
TIRZ-30
Tirzepatide 30 mg
TIRZ-10
Tirzepatide 10 mg
Semaglutide 20mg
Semaglutide 20 mg — GLP-1 Agonist